F&C Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

F&C Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$14.3M	Sell	271,123 -26,757	-9%	-$1.24M	0.18%	165
2013 Q4	$11.9M	Buy	297,880 +208,863	+235%	+$8.22M	0.15%	218
2013 Q3	$3.36M	Buy	89,017 +13,729	+18%	+$536K	0.04%	383
2013 Q2	$2.95M	Buy	+75,288	New	+$2.93M	0.04%	404

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

F&C Asset Management's TEVA Position: Q1 2014 in Review

F&C Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 9% in Q1 2014, selling an estimated $1.24M and leaving 271,123 shares worth $14.3M. The position accounts for 0.18% of the portfolio, ranked #165.

F&C Asset Management first reported a position in TEVA in Q2 2013 and has held it in 4 quarters since. 770 funds tracked by Wall St. Rank hold TEVA as of Q1 2014.

F&C Asset Management held 271,123 shares of Teva Pharmaceuticals worth $14.3M as of Q1 2014.
F&C Asset Management sold 26,757 Teva Pharmaceuticals shares in Q1 2014, an estimated $1.24M.
Teva Pharmaceuticals made up 0.18% of F&C Asset Management's portfolio in Q1 2014, its #165 holding.
F&C Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 4 quarters since.
770 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.